Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
PETS 
PetMed Express Inc (PETS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/11/2025: PETS (2-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
2 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $2.75
1 Year Target Price $2.75
| 0 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 9.41% | Avg. Invested days 43 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 12/11/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 63.68M USD | Price to earnings Ratio - | 1Y Target Price 2.75 |
Price to earnings Ratio - | 1Y Target Price 2.75 | ||
Volume (30-day avg) 2 | Beta 0.77 | 52 Weeks Range 1.57 - 5.80 | Updated Date 12/11/2025 |
52 Weeks Range 1.57 - 5.80 | Updated Date 12/11/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.5 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -2.76% | Operating Margin (TTM) -27.51% |
Management Effectiveness
Return on Assets (TTM) -3.25% | Return on Equity (TTM) -6.9% |
Valuation
Trailing PE - | Forward PE 17.92 | Enterprise Value -16307305 | Price to Sales(TTM) 0.28 |
Enterprise Value -16307305 | Price to Sales(TTM) 0.28 | ||
Enterprise Value to Revenue 0.02 | Enterprise Value to EBITDA 0.63 | Shares Outstanding 21369521 | Shares Floating 13630425 |
Shares Outstanding 21369521 | Shares Floating 13630425 | ||
Percent Insiders 31.05 | Percent Institutions 35.39 |
Upturn AI SWOT
PetMed Express Inc
Company Overview
History and Background
PetMed Express Inc., founded in 1996, is a leading online pet pharmacy in the United States. The company revolutionized the way pet owners purchase prescription and non-prescription pet medications and supplies by offering convenience and competitive pricing. It has since expanded its product offerings and solidified its position as a trusted source for pet healthcare products.
Core Business Areas
- Prescription Pet Medications: PetMed Express's core business involves dispensing a wide range of prescription medications for various pet ailments, including flea and tick prevention, heartworm medication, antibiotics, and pain relief. They work with licensed veterinarians to fulfill prescriptions.
- Over-the-Counter Pet Products: The company also offers a comprehensive selection of non-prescription items such as vitamins, supplements, dental care products, grooming supplies, and specialty foods.
- Pet Supplies and Accessories: Beyond medications and health products, PetMed Express provides a variety of pet supplies including toys, beds, crates, and travel accessories.
Leadership and Structure
PetMed Express Inc. is led by a management team with expertise in e-commerce, veterinary pharmaceuticals, and customer service. The company operates primarily as an online retailer, with its corporate headquarters in the United States. Specific details on the current CEO and board members would require accessing the latest corporate filings.
Top Products and Market Share
Key Offerings
- Flea and Tick Medications: This category includes popular brands like Frontline, Advantage, and NexGard. Competitors include other online pharmacies, brick-and-mortar pet stores, and veterinary clinics. Market share data is not readily available for specific product categories but this is a significant revenue driver.
- Heartworm Preventatives: Products such as Heartgard Plus and K9 Advantix II are crucial for pet health. Competitors are similar to flea and tick medications. This is another core product segment.
- Joint Supplements: A growing segment driven by the aging pet population, including brands like Dasuquin and Glucosamine. Competitors include a wide range of pet health product providers.
Market Dynamics
Industry Overview
The pet pharmacy and pet care industry is experiencing robust growth, fueled by increasing pet ownership, the humanization of pets, and a greater willingness among owners to invest in their pets' health and well-being. The e-commerce segment of this market is particularly strong, offering convenience and wider product selection.
Positioning
PetMed Express is positioned as a convenient and cost-effective online retailer for pet medications and supplies. Its competitive advantages include its established brand recognition, a wide selection of products, and a user-friendly online platform. The company's direct-to-consumer model bypasses some of the overhead associated with traditional brick-and-mortar retailers.
Total Addressable Market (TAM)
The total addressable market for pet medications and supplies in the US is substantial and growing, estimated to be in the tens of billions of dollars annually. PetMed Express operates within this large and expanding TAM, focusing on the online segment which represents a significant portion and continues to gain market share from traditional channels.
Upturn SWOT Analysis
Strengths
- Established brand recognition and customer loyalty.
- Wide product selection of prescription and OTC pet medications and supplies.
- Convenient online ordering and home delivery services.
- Relationships with veterinary professionals.
- Strong customer service infrastructure.
Weaknesses
- Dependence on third-party shipping providers.
- Potential for increased competition from larger online retailers and direct-to-consumer brands.
- Regulatory changes impacting prescription drug sales.
- Limited physical presence for direct customer interaction.
Opportunities
- Expansion of product lines into niche or specialized pet health products.
- Partnerships with veterinary clinics for co-branded services or referrals.
- Leveraging data analytics to personalize customer offers and improve inventory management.
- Growth in the telehealth and remote veterinary services market.
- International market expansion (long-term).
Threats
- Intensifying competition from online pharmacies, big-box retailers, and direct-to-manufacturer sales.
- Changes in prescribing habits or direct purchasing by consumers from manufacturers.
- Economic downturns impacting discretionary spending on pets.
- Data security breaches and privacy concerns.
- Supply chain disruptions affecting product availability.
Competitors and Market Share
Key Competitors
- Chewy Inc. (CHWY)
- Amazon.com Inc. (AMZN)
- Walmart Inc. (WMT)
- Local Veterinary Clinics
Competitive Landscape
PetMed Express faces significant competition from larger, more diversified e-commerce players like Amazon and Chewy, which have broader customer bases and extensive logistics networks. While PetMed Express excels in its specialized focus on pet prescriptions, it must continually differentiate itself through service, price, and product breadth to maintain and grow its market share against these giants and the fragmented market of local veterinarians.
Growth Trajectory and Initiatives
Historical Growth: Historically, PetMed Express has experienced growth driven by the increasing adoption of e-commerce for pet supplies and the consistent demand for pet medications. However, recent years may show moderating growth due to increased competition and market saturation.
Future Projections: Future growth projections are contingent on the company's ability to innovate, adapt to market changes, and maintain its competitive edge. Analyst estimates, if available, would provide insights into expected revenue and earnings growth.
Recent Initiatives: Recent initiatives might include efforts to enhance the online customer experience, expand product offerings, optimize marketing strategies, and potentially explore new service areas within the pet care ecosystem.
Summary
PetMed Express Inc. is a well-established online pet pharmacy with a strong brand presence. Its core strength lies in its specialized focus on pet medications and a wide product selection. However, it faces intense competition from larger e-commerce players and the fragmented veterinary market. To thrive, PetMed Express needs to continuously innovate its customer experience, expand its service offerings, and maintain competitive pricing while navigating evolving industry dynamics.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company financial reports (e.g., 10-K, 10-Q filings with the SEC)
- Financial news and data providers (e.g., Bloomberg, Refinitiv, Yahoo Finance)
- Industry research reports
Disclaimers:
This JSON output is generated for informational purposes only and does not constitute financial advice. All data is based on publicly available information and may not be exhaustive or up-to-date. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. Market share data is estimated and subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About PetMed Express Inc
Exchange NASDAQ | Headquaters Delray Beach, FL, United States | ||
IPO Launch date 1999-04-26 | CEO - | ||
Sector Healthcare | Industry Pharmaceutical Retailers | Full time employees 173 | Website https://www.1800petmeds.com |
Full time employees 173 | Website https://www.1800petmeds.com | ||
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.